Estimates Revisions Centessa Pharmaceuticals plc
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.02 USD | +0.38% |
|
+0.76% | +60.02% |
| 05-26 | Eli Lilly to Acquire Three Vaccine Developers for Up to $3.83 Billion | MT |
| 05-20 | Eli Lilly Buys Engage Biologics for Up to $202 Million | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CNTA Stock
- Consensus Centessa Pharmaceuticals plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
